Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test Cardiomyopathies Gene Panel is within 14-21 business days from the receipt of the sample.

What are the prerequisites for the test Cardiomyopathies Gene Panel

  • Consultation with a medical geneticist or genetic counselor
  • Family history review
  • Physical examination
  • Electrocardiogram (ECG)
  • Echocardiogram
  • Blood test for creatine kinase levels
  • Complete blood count (CBC)
  • Cardiac MRI

What are the measure values for the test Cardiomyopathies Gene Panel

  • Gene Panel Name: Cardiomyopathies Gene Panel
  • Number of Genes: 50
  • Sequencing Method: Next Generation Sequencing (NGS)
  • Deletion/Duplication Analysis: Yes
  • Clinical Sensitivity: 90%
  • Analytical Sensitivity: 99%
  • Turnaround Time: 4-6 weeks

What does this test Cardiomyopathies Gene Panel identify?

  • Arrhythmogenic right ventricular cardiomyopathy (ARVC): This condition is characterized by abnormal heart rhythm and the replacement of heart muscle with fatty or fibrous tissue.
  • Dilated cardiomyopathy (DCM): DCM is a condition where the heart becomes enlarged and weakened, leading to decreased pumping ability.
  • Hypertrophic cardiomyopathy (HCM): HCM is a condition where the heart muscle becomes thickened, making it harder for the heart to pump blood effectively.
  • Restrictive cardiomyopathy (RCM): RCM is a condition where the heart muscle becomes stiff, leading to difficulty filling with blood.
  • Left ventricular noncompaction (LVNC): LVNC is a condition where the walls of the heart's left ventricle have a spongy appearance, leading to potential heart failure.

Why is this test Cardiomyopathies Gene Panel taken?

Reasons for taking Cardiomyopathies Gene Panel Test

Cardiomyopathies are a group of diseases that affect the heart muscle, leading to abnormal heart function. The Cardiomyopathies Gene Panel Test is taken to help diagnose and manage individuals with suspected cardiomyopathy. This test analyzes a panel of genes known to be associated with various types of cardiomyopathies, including hypertrophic cardiomyopathy, dilated cardiomyopathy, and restrictive cardiomyopathy.

Some of the common reasons for taking the Cardiomyopathies Gene Panel Test include:

  • Family history of cardiomyopathy
  • Unexplained heart failure or heart muscle abnormalities
  • Abnormal heart rhythm or sudden cardiac arrest
  • Screening for genetic mutations in individuals at risk for cardiomyopathy
  • Guiding treatment decisions, such as medication selection or cardiac device implantation

Results from the Cardiomyopathies Gene Panel Test can help healthcare providers better understand the underlying genetic cause of a patient's cardiomyopathy, allowing for personalized treatment and management strategies. Early detection of genetic mutations associated with cardiomyopathies can also help identify at-risk family members who may benefit from genetic counseling and screening.

Popular FAQs on Test

A Cardiomyopathies Gene Panel test is a genetic test that analyzes a panel of genes known to be associated with various types of cardiomyopathies, including hypertrophic cardiomyopathy, dilated cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy.
The test may be recommended for individuals with a family history of cardiomyopathy, young individuals with unexplained cardiac symptoms, or individuals who have been diagnosed with cardiomyopathy and want to determine the underlying genetic cause.
The test is typically performed using a blood sample. The sample is sent to a laboratory where the DNA is extracted and analyzed for mutations in the genes included in the panel.
The test can help to identify the specific genetic mutation causing the cardiomyopathy, which can inform treatment decisions, provide information about the risk of disease progression, and help with family planning.
While the test can identify known genetic mutations associated with cardiomyopathies, it may not detect all possible genetic causes of the condition. Additionally, the test results may not always be straightforward to interpret.

Customer Google Rating